Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Servier Acquires Shire Oncology Business For $2.4bn

Executive Summary

French pharma Servier takes step to meet its strategic ambition of becoming a global player in oncology by acquiring Shire's cancer franchise for $2.4bn

Advertisement

Related Content

Biopharma Quarterly Dealmaking Statistics, Q2 2018
Takeda/Shire Deal Stands Fifth Largest In Biopharma M&A
Pharma Q1 Results Preview: Shire, AbbVie, Bristol, Sanofi, Allergan
Sweet Enough? Takeda Raises, Adds Cash To Shire Offer
Pharma Q1 Results Preview: Lilly, Biogen, Amgen, GSK & Roche
Shire Rejects Multiple Equity-Loaded Takeda Offers, Allergan Declines To Bid
Servier's Shire Oncology Buy Gives Base For US Expansion

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC122899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel